| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-catenin binding | 2.31e-05 | 120 | 141 | 7 | GO:0008013 | |
| GeneOntologyCellularComponent | synaptic membrane | ERBB3 ANK3 PODXL HCN1 KCNAB2 GRIP1 MET AKAP9 TIAM1 TENM3 SCN1A IGSF9B CDH8 GABRA4 | 4.83e-05 | 583 | 143 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | cell-cell junction | ANK3 PODXL MTSS1 ASH1L ESAM PIKFYVE FNDC1 DST TIAM1 YAP1 AJM1 SCN1A CDH8 GAB1 | 5.59e-05 | 591 | 143 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 ANK3 PCLO KCNAB2 NR3C1 GRIP1 DST AKAP9 TIAM1 PLXNA4 IGSF9B PRNP | 1.11e-04 | 477 | 143 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 ANK3 PCLO KCNAB2 NR3C1 GRIP1 DST AKAP9 TIAM1 IGSF9B PRNP GABRA4 | 1.81e-04 | 503 | 143 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 ANK3 PCLO KCNAB2 NR3C1 GRIP1 DST AKAP9 TIAM1 PLXNA4 IGSF9B PRNP | 2.59e-04 | 523 | 143 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 2.76e-04 | 4 | 143 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 ANK3 PCLO KCNAB2 NR3C1 GRIP1 DST AKAP9 TIAM1 IGSF9B PRNP | 2.81e-04 | 451 | 143 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | anchoring junction | ANK3 PODXL PPFIA1 FERMT1 MTSS1 ASH1L ASAP3 ESAM PIKFYVE FNDC1 DST TIAM1 YAP1 AJM1 SCN1A CDH8 GAB1 | 3.73e-04 | 976 | 143 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 4.05e-04 | 91 | 143 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.84e-04 | 405 | 143 | 10 | GO:0045211 | |
| GeneOntologyCellularComponent | potassium channel complex | 7.46e-04 | 104 | 143 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | axon initial segment | 1.01e-03 | 29 | 143 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | axon | TANC2 ANK3 HCN1 PPFIA1 PCLO KCNAB2 VPS16 GRIP1 DST TIAM1 TENM3 SCN1A PUM1 CDH8 PRNP | 1.18e-03 | 891 | 143 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 PODXL HCN1 PCLO DVL3 KCNAB2 NR3C1 ABLIM3 GRIP1 AKAP9 TIAM1 TENM3 PLXNA4 CDH8 | 1.46e-03 | 817 | 143 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | TANC2 ERBB3 ANK3 HCN1 PPFIA1 PCLO KCNAB2 NR3C1 GRIP1 MET DST AKAP9 TIAM1 IGSF9B PRNP GABRA4 | 1.64e-03 | 1018 | 143 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 DPP6 ANK3 HCN1 PPFIA1 PCLO SREBF2 VPS16 NR3C1 GRIP1 MET AKAP9 TIAM1 SCN1A IGSF9B PRNP GABRA4 PMM2 | 1.83e-03 | 1228 | 143 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic density membrane | 2.02e-03 | 10 | 143 | 2 | GO:0099147 | |
| GeneOntologyCellularComponent | dendrite | TANC2 ANK3 HCN1 PPFIA1 PCLO SREBF2 NR3C1 GRIP1 MET AKAP9 TIAM1 IGSF9B PRNP GABRA4 | 2.29e-03 | 858 | 143 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 ANK3 HCN1 PPFIA1 PCLO SREBF2 NR3C1 GRIP1 MET AKAP9 TIAM1 IGSF9B PRNP GABRA4 | 2.34e-03 | 860 | 143 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | cell leading edge | PODXL HCN1 FERMT1 MTSS1 ASAP3 ADGRV1 ABLIM3 DST TIAM1 GABRA4 | 2.35e-03 | 500 | 143 | 10 | GO:0031252 |
| GeneOntologyCellularComponent | oxoglutarate dehydrogenase complex | 2.45e-03 | 11 | 143 | 2 | GO:0045252 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.87e-03 | 141 | 143 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 2.93e-03 | 12 | 143 | 2 | GO:0098892 | |
| HumanPheno | Abnormal thought pattern | TANC2 ANK3 HCN1 ASH1L KCNAB2 CHD8 VPS16 ADGRV1 NR3C1 TIAM1 CSNK2A1 SCN1A PUM1 SPEN PRNP | 2.96e-05 | 404 | 58 | 15 | HP:5200269 |
| HumanPheno | Obsessive-compulsive trait | 2.99e-05 | 33 | 58 | 5 | HP:0008770 | |
| HumanPheno | Perseverative thought | TANC2 ANK3 HCN1 ASH1L KCNAB2 CHD8 VPS16 ADGRV1 TIAM1 CSNK2A1 SCN1A PUM1 SPEN PRNP | 5.81e-05 | 377 | 58 | 14 | HP:0030223 |
| HumanPheno | Disordered formal thought process | TANC2 ANK3 HCN1 ASH1L KCNAB2 CHD8 VPS16 ADGRV1 TIAM1 CSNK2A1 SCN1A PUM1 SPEN PRNP | 7.53e-05 | 386 | 58 | 14 | HP:0025769 |
| HumanPheno | Atrophy/Degeneration affecting the cerebrum | DPYD DMXL2 HIVEP2 HCN1 PCLO KCNAB2 ESAM SLC35B2 VPS16 ADGRV1 SEPSECS TIAM1 SCN1A ZNF335 OGDHL PUM1 SPEN KDM6A DYNC1I2 PRNP | 9.33e-05 | 733 | 58 | 20 | HP:0007369 |
| HumanPheno | Brain atrophy | DPYD DMXL2 HIVEP2 PODXL HCN1 PCLO KCNAB2 ESAM SLC35B2 VPS16 ADGRV1 SEPSECS TIAM1 SCN1A ZNF335 OGDHL PUM1 SPEN KDM6A DYNC1I2 PRNP | 1.06e-04 | 802 | 58 | 21 | HP:0012444 |
| HumanPheno | Brain very small | DPYD DMXL2 HIVEP2 PODXL HCN1 PCLO KCNAB2 ESAM SLC35B2 VPS16 ADGRV1 SEPSECS TIAM1 SCN1A ZNF335 OGDHL PUM1 SPEN KDM6A DYNC1I2 PRNP | 1.06e-04 | 802 | 58 | 21 | HP:0001322 |
| Domain | TMEM131-like | 5.50e-05 | 2 | 139 | 2 | IPR022113 | |
| Domain | 2-oxogl_dehyd_N | 5.50e-05 | 2 | 139 | 2 | IPR032106 | |
| Domain | TMEM131_like | 5.50e-05 | 2 | 139 | 2 | PF12371 | |
| Domain | 2-oxogl_dehyd_N | 5.50e-05 | 2 | 139 | 2 | PF16078 | |
| Domain | SEA | 1.38e-04 | 14 | 139 | 3 | SM00200 | |
| Domain | 2oxoglutarate_DH_E1 | 1.64e-04 | 3 | 139 | 2 | IPR011603 | |
| Domain | KGD_C | 1.64e-04 | 3 | 139 | 2 | IPR031717 | |
| Domain | OxoGdeHyase_C | 1.64e-04 | 3 | 139 | 2 | PF16870 | |
| Pubmed | EPN3 ANK3 EXPH5 ASH1L DVL3 PEX6 GRIP1 PHKA2 LIMK2 DST TENM3 PUM1 KDM6A | 1.10e-06 | 591 | 143 | 13 | 15231748 | |
| Pubmed | DMXL2 ATP6AP1 RUNDC3B SREBF2 PEX6 VPS16 JPH1 PIKFYVE DST TMEM131L TMEM131 SCFD1 | 1.29e-06 | 504 | 143 | 12 | 34432599 | |
| Pubmed | 1.29e-06 | 257 | 143 | 9 | 30945288 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 HIVEP2 EXPH5 PPFIA1 GRIP1 LIMK2 DST AKAP9 TIAM1 YAP1 STARD9 KIAA1217 PUM1 CDC25C GAB1 | 2.88e-06 | 861 | 143 | 15 | 36931259 |
| Pubmed | SOX6 DMXL2 ERBB3 HIVEP2 ANK3 HCN1 PEG3 ASH1L DVL3 KCNAB2 JPH1 PLEKHH1 FRY HEATR6 DST TIAM1 TMEM131 KDM6A | 5.95e-06 | 1285 | 143 | 18 | 35914814 | |
| Pubmed | TANC2 DPP6 DMXL2 FAM120B ATP6AP1 ANK3 PPFIA1 PCLO KCNAB2 ABLIM3 OGDH DST EIF2S1 AJM1 CSNK2A1 KIAA1217 PLXNA4 OGDHL PRNP | 6.88e-06 | 1431 | 143 | 19 | 37142655 | |
| Pubmed | Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. | 8.00e-06 | 10 | 143 | 3 | 15096597 | |
| Pubmed | 1.04e-05 | 421 | 143 | 10 | 36976175 | ||
| Pubmed | 1.10e-05 | 11 | 143 | 3 | 14522873 | ||
| Pubmed | DMXL2 ATP6AP1 ANK3 PPFIA1 NR3C1 OGDH JPH1 ACSL3 MET AKAP9 TIAM1 EIF2S1 NUP210 GHITM TMEM131L DDX23 TMEM131 SCFD1 GAB1 | 1.18e-05 | 1487 | 143 | 19 | 33957083 | |
| Pubmed | 1.46e-05 | 12 | 143 | 3 | 21945074 | ||
| Pubmed | Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. | 1.46e-05 | 12 | 143 | 3 | 25438054 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 10222050 | ||
| Pubmed | Cone-Driven Retinal Responses Are Shaped by Rod But Not Cone HCN1. | 1.68e-05 | 2 | 143 | 2 | 35437278 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 29705776 | ||
| Pubmed | MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. | 1.68e-05 | 2 | 143 | 2 | 17463250 | |
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 1.68e-05 | 2 | 143 | 2 | 14646071 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 28442529 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 22366451 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 17263731 | ||
| Pubmed | Met-HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells. | 1.68e-05 | 2 | 143 | 2 | 35249128 | |
| Pubmed | Novel regulators of PrPC biosynthesis revealed by genome-wide RNA interference. | 1.68e-05 | 2 | 143 | 2 | 34705895 | |
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 1.68e-05 | 2 | 143 | 2 | 12860116 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 25798835 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 18854872 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 15319348 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 36155332 | ||
| Pubmed | Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells. | 1.68e-05 | 2 | 143 | 2 | 19748890 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12766170 | ||
| Pubmed | Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. | 1.68e-05 | 2 | 143 | 2 | 16618805 | |
| Pubmed | Assignment of casein kinase 2 alpha sequences to two different human chromosomes. | 1.68e-05 | 2 | 143 | 2 | 1577469 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21750987 | ||
| Pubmed | Kinomics Screening Identifies Aberrant Phosphorylation of CDC25C in FLT3-ITD-positive AML. | 1.68e-05 | 2 | 143 | 2 | 27919943 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 24127237 | ||
| Pubmed | Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3. | 1.68e-05 | 2 | 143 | 2 | 30421568 | |
| Pubmed | Molecular cloning of the human casein kinase II alpha subunit. | 1.68e-05 | 2 | 143 | 2 | 2752008 | |
| Pubmed | Structure and sequence of an intronless gene for human casein kinase II-alpha subunit. | 1.68e-05 | 2 | 143 | 2 | 8420794 | |
| Pubmed | PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. | 1.68e-05 | 2 | 143 | 2 | 19139719 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 29961073 | ||
| Pubmed | 1.70e-05 | 446 | 143 | 10 | 24255178 | ||
| Pubmed | TANC2 DMXL2 ANK3 HCN1 PCLO DVL3 KCNAB2 BSDC1 OGDH GMPS ACSL3 MET AJM1 SCN1A KIAA1217 PRNP | 1.96e-05 | 1139 | 143 | 16 | 36417873 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EPN3 ERBB3 ANK3 FERMT1 DVL3 ABLIM3 DST TENM3 YAP1 KIAA1217 GAB1 | 2.36e-05 | 565 | 143 | 11 | 25468996 |
| Pubmed | CDV3 DVL3 BSDC1 SLC35B2 JPH1 ACSL3 DST TMEM131L TMEM131 PRR14L SCFD1 | 2.48e-05 | 568 | 143 | 11 | 37774976 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 3.89e-05 | 303 | 143 | 8 | 25056061 | |
| Pubmed | TANC2 NCOA3 DMXL2 ANK3 HCN1 PPFIA1 KCNAB2 CHD8 ABLIM3 FRY DST AKAP9 CSNK2A1 KIAA1217 | 4.63e-05 | 963 | 143 | 14 | 28671696 | |
| Pubmed | Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation. | 5.02e-05 | 3 | 143 | 2 | 15684395 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 32185219 | ||
| Pubmed | SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy. | 5.02e-05 | 3 | 143 | 2 | 25823783 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 2174700 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 17438369 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 1766873 | ||
| Pubmed | Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung. | 5.02e-05 | 3 | 143 | 2 | 21043826 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 29138287 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 24268649 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 10512748 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 16973615 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 29679912 | ||
| Pubmed | Crystallization and preliminary characterization of crystals of human protein kinase CK2. | 5.02e-05 | 3 | 143 | 2 | 11092945 | |
| Pubmed | Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. | 5.02e-05 | 3 | 143 | 2 | 18192688 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 12102635 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 25400108 | ||
| Pubmed | Degradation of the GAB1 adaptor by the ubiquitin-proteasome pathway hampers HGF/SF-MET signaling. | 5.02e-05 | 3 | 143 | 2 | 21782801 | |
| Pubmed | SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. | 5.02e-05 | 3 | 143 | 2 | 33046796 | |
| Pubmed | Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer. | 5.02e-05 | 3 | 143 | 2 | 20625391 | |
| Pubmed | High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer. | 5.02e-05 | 3 | 143 | 2 | 24901400 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 19881549 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 35840017 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 7835904 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 30256410 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 30821074 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 22915589 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 17363573 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 10893266 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 15064744 | ||
| Pubmed | Retinal Degeneration Triggers the Activation of YAP/TEAD in Reactive MĂĽller Cells. | 5.02e-05 | 3 | 143 | 2 | 28384715 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 34795238 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 21918175 | ||
| Pubmed | Histone demethylase Utx regulates differentiation and mineralization in osteoblasts. | 5.02e-05 | 3 | 143 | 2 | 25920016 | |
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 17894550 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 22188362 | ||
| Pubmed | 5.02e-05 | 3 | 143 | 2 | 22092298 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.31e-05 | 18 | 143 | 3 | 18834073 | |
| Pubmed | 5.49e-05 | 234 | 143 | 7 | 36243803 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 6.43e-05 | 420 | 143 | 9 | 28065597 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP6AP1 RBMS1 SMOC1 ACSL3 SEPSECS HEATR6 AKAP9 CSNK2A1 NUP210 GHITM SCFD1 DYNC1I2 | 7.06e-05 | 754 | 143 | 12 | 33060197 |
| Pubmed | 7.37e-05 | 20 | 143 | 3 | 33397958 | ||
| Pubmed | 7.85e-05 | 335 | 143 | 8 | 15741177 | ||
| Pubmed | ANK3 PODXL PPFIA1 FERMT1 BSDC1 MUC16 MET DST TENM3 SCFD1 SPEN GAB1 | 9.37e-05 | 777 | 143 | 12 | 35844135 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 17452457 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 26496879 | ||
| Pubmed | GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression. | 1.00e-04 | 4 | 143 | 2 | 19074285 | |
| Pubmed | A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. | 1.00e-04 | 4 | 143 | 2 | 28114269 | |
| Pubmed | Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma. | 1.00e-04 | 4 | 143 | 2 | 32220262 | |
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 11062072 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 30056064 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 12475979 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 28416184 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 16849011 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 26329844 | ||
| Pubmed | 1.00e-04 | 4 | 143 | 2 | 15225637 | ||
| Interaction | ANKRD36B interactions | 3.56e-06 | 60 | 139 | 6 | int:ANKRD36B | |
| Interaction | LYN interactions | ERBB3 FLT3 ANK3 PPFIA1 JPH1 ACSL3 MET DST TIAM1 YAP1 CSNK2A1 KIAA1217 DDX23 IGSF9B CSNK2A3 NKAPL GAB1 | 9.78e-06 | 720 | 139 | 17 | int:LYN |
| GeneFamily | CD molecules|Mucins | 1.34e-04 | 21 | 87 | 3 | 648 | |
| GeneFamily | PDZ domain containing | 8.35e-04 | 152 | 87 | 5 | 1220 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 DPYD HIVEP2 RBMS1 PPFIA1 NR3C1 GMPS PIKFYVE ACSL3 DST AKAP9 TIAM1 YAP1 TMEM131 PUM1 SPEN PMM2 | 5.56e-10 | 466 | 140 | 17 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 DPYD DMXL2 HIVEP2 PODXL RBMS1 PPFIA1 NR3C1 ABLIM3 GMPS PIKFYVE ACSL3 DST AKAP9 TIAM1 YAP1 CSNK2A1 TMEM131L TMEM131 PUM1 SPEN PMM2 | 1.04e-09 | 856 | 140 | 22 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 DPP6 ANK3 RUNDC3B PCLO PEG3 MTSS1 AMER3 ABLIM3 JPH1 GRIP1 FRY KIAA1549L AKAP9 SCN1A PLXNA4 OGDHL IGSF9B PAX5 SARDH CDH8 PRNP | 1.03e-07 | 1106 | 140 | 22 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.23e-07 | 212 | 140 | 10 | M39221 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 ERBB3 HIVEP2 EXPH5 PIKFYVE DST AKAP9 TMEM131L LSM14A PUM1 SPEN | 6.74e-07 | 300 | 140 | 11 | M8702 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TANC2 NCOA3 DPP6 DMXL2 CDV3 HIVEP2 EXPH5 PCLO PEG3 MTSS1 ASH1L NR3C1 PIKFYVE DST TIAM1 KLHDC8A GHITM DIP2C PRNP | 7.25e-07 | 946 | 140 | 19 | M39169 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | DPP6 ANK3 RUNDC3B PCLO PEG3 MTSS1 ABLIM3 FRY KIAA1549L AKAP9 SCN1A PLXNA4 OGDHL PAX5 CDH8 | 5.68e-06 | 703 | 140 | 15 | M39070 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP | 6.60e-06 | 183 | 140 | 8 | M12621 | |
| Coexpression | PILON_KLF1_TARGETS_UP | ANK3 PODXL RBMS1 PPFIA1 PEG3 ESAM CHD8 GMPS UGT2B4 UGT2B7 ING4 PMM2 | 3.52e-05 | 541 | 140 | 12 | MM1061 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 4.01e-05 | 117 | 140 | 6 | M45663 | |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | 4.93e-05 | 242 | 140 | 8 | M12816 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 6.64e-05 | 79 | 140 | 5 | M7102 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_UP | 1.03e-04 | 200 | 140 | 7 | M9406 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP | 1.03e-04 | 200 | 140 | 7 | M4576 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP | 1.03e-04 | 200 | 140 | 7 | M6061 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | ERBB3 MXRA5 HIVEP2 PODXL ASAP3 BSDC1 PLEKHH1 MRPS30 LIMK2 AKAP9 METTL9 CSNK2A1 KIAA1217 LSM14A | 1.11e-04 | 807 | 140 | 14 | M16651 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 1.25e-04 | 437 | 140 | 10 | M4665 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.40e-04 | 210 | 140 | 7 | M2010 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 1.16e-05 | 118 | 137 | 7 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.58e-05 | 90 | 137 | 6 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX6 DMXL2 PPFIA1 PCLO ASH1L KIAA1614 JPH1 GRIP1 HEATR6 KIAA1549L AKAP9 NUP210 TMEM131L PRR14L KDM6A CDH8 PMM2 | 2.61e-05 | 831 | 137 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.79e-05 | 259 | 137 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 4.96e-05 | 101 | 137 | 6 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.47e-05 | 328 | 137 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_500 | 8.32e-05 | 36 | 137 | 4 | gudmap_developingGonad_P2_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.09e-04 | 225 | 137 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.40e-04 | 298 | 137 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | ERBB3 PCLO EMID1 FERMT1 KCNAB2 ADGRV1 NR3C1 SMOC1 JPH1 PLEKHH1 IGSF10 MET FNDC1 KIAA1549L KIAA1217 NUP210 IL17RD | 1.80e-04 | 973 | 137 | 17 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200 | 1.89e-04 | 183 | 137 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 2.36e-04 | 19 | 137 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 2.38e-04 | 86 | 137 | 5 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.84e-04 | 259 | 137 | 8 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.88e-04 | 139 | 137 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX6 DPYD PCLO CHD8 JPH1 GRIP1 DST KIAA1549L AKAP9 STARD9 NUP210 SARDH CDH8 | 3.23e-04 | 654 | 137 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 3.53e-04 | 52 | 137 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 3.60e-04 | 94 | 137 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 3.61e-04 | 145 | 137 | 6 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 3.88e-04 | 147 | 137 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 4.23e-04 | 23 | 137 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 4.23e-04 | 23 | 137 | 3 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | PODXL RBMS1 PEG3 MUC16 SMOC1 TGM3 TENM3 KIAA1217 PLXNA4 GABRA4 | 4.29e-04 | 423 | 137 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.34e-04 | 276 | 137 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 4.36e-04 | 98 | 137 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 5.32e-04 | 156 | 137 | 6 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_200 | 5.37e-04 | 58 | 137 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 5.45e-04 | 25 | 137 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 5.69e-04 | 158 | 137 | 6 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 5.73e-04 | 59 | 137 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | TANC2 PODXL PEG3 MUC16 SMOC1 ABLIM3 TGM3 DST AKAP9 STARD9 PLXNA4 TMEM131L KDM6A GABRA4 | 6.05e-04 | 791 | 137 | 14 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_100 | 6.13e-04 | 26 | 137 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | ERBB3 ANK3 PCLO EMID1 FERMT1 ADGRV1 NR3C1 GRIP1 PLEKHH1 IGSF10 MET FNDC1 KIAA1549L NUP210 IL17RD CDH8 | 6.17e-04 | 984 | 137 | 16 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200 | 6.49e-04 | 162 | 137 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | NCOA3 DPYD PEG3 ASH1L CHD8 NR3C1 GMPS FNDC1 STARD9 CSNK2A1 ING4 PUM1 KDM6A GABRA4 | 6.52e-04 | 797 | 137 | 14 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | PODXL PEG3 SMOC1 ABLIM3 TGM3 DST AKAP9 TENM3 STARD9 PLXNA4 TMEM131L NKAPL KDM6A GABRA4 | 7.01e-04 | 803 | 137 | 14 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.30e-08 | 194 | 142 | 9 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-08 | 198 | 142 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-08 | 200 | 142 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.70e-08 | 200 | 142 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 7.01e-08 | 168 | 142 | 8 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-07 | 176 | 142 | 8 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.53e-07 | 186 | 142 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.73e-07 | 189 | 142 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-07 | 190 | 142 | 8 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.81e-07 | 190 | 142 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-07 | 190 | 142 | 8 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-07 | 192 | 142 | 8 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.96e-07 | 192 | 142 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 2.04e-07 | 193 | 142 | 8 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 193 | 142 | 8 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.04e-07 | 193 | 142 | 8 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.12e-07 | 194 | 142 | 8 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-07 | 194 | 142 | 8 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.20e-07 | 195 | 142 | 8 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-07 | 196 | 142 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.29e-07 | 196 | 142 | 8 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-07 | 198 | 142 | 8 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-07 | 198 | 142 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-07 | 198 | 142 | 8 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-07 | 198 | 142 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.67e-07 | 200 | 142 | 8 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.20e-07 | 153 | 142 | 7 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-07 | 153 | 142 | 7 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.38e-07 | 157 | 142 | 7 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.38e-07 | 160 | 142 | 7 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.38e-07 | 160 | 142 | 7 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.07e-06 | 166 | 142 | 7 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-06 | 168 | 142 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 179 | 142 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 2.06e-06 | 183 | 142 | 7 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 185 | 142 | 7 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 185 | 142 | 7 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 185 | 142 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-06 | 187 | 142 | 7 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.37e-06 | 187 | 142 | 7 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-06 | 188 | 142 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.55e-06 | 189 | 142 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.55e-06 | 189 | 142 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-06 | 190 | 142 | 7 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.64e-06 | 190 | 142 | 7 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-06 | 190 | 142 | 7 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.64e-06 | 190 | 142 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.73e-06 | 191 | 142 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 191 | 142 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.73e-06 | 191 | 142 | 7 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.73e-06 | 191 | 142 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.73e-06 | 191 | 142 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.73e-06 | 191 | 142 | 7 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-06 | 191 | 142 | 7 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.82e-06 | 192 | 142 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.82e-06 | 192 | 142 | 7 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-06 | 193 | 142 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-06 | 193 | 142 | 7 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.92e-06 | 193 | 142 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.92e-06 | 193 | 142 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.92e-06 | 193 | 142 | 7 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-06 | 193 | 142 | 7 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 193 | 142 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-06 | 193 | 142 | 7 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-06 | 193 | 142 | 7 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-06 | 193 | 142 | 7 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-06 | 193 | 142 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-06 | 193 | 142 | 7 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.02e-06 | 194 | 142 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 3.02e-06 | 194 | 142 | 7 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 3.02e-06 | 194 | 142 | 7 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-06 | 194 | 142 | 7 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-06 | 194 | 142 | 7 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-06 | 194 | 142 | 7 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 195 | 142 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 195 | 142 | 7 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 3.13e-06 | 195 | 142 | 7 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.24e-06 | 196 | 142 | 7 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-06 | 197 | 142 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.46e-06 | 198 | 142 | 7 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-06 | 198 | 142 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-06 | 198 | 142 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.46e-06 | 198 | 142 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.46e-06 | 198 | 142 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.58e-06 | 199 | 142 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.58e-06 | 199 | 142 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.70e-06 | 200 | 142 | 7 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.70e-06 | 200 | 142 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.82e-06 | 189 | 141 | 9 | 4271_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.95e-06 | 190 | 141 | 9 | 4322_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.17e-05 | 171 | 141 | 8 | 7535_DN | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 1.38e-05 | 175 | 141 | 8 | 1653_UP | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.00e-05 | 195 | 141 | 8 | 3330_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 3351_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 3350_UP | |
| Drug | Nicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 5775_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 4464_DN | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; HL60; HT_HG-U133A | 3.47e-05 | 199 | 141 | 8 | 2514_UP | |
| Drug | p-cymen-8-ol | 3.81e-05 | 2 | 141 | 2 | CID000014529 | |
| Drug | apiol | 3.81e-05 | 2 | 141 | 2 | CID000010659 | |
| Drug | AC1L2I2N | 3.81e-05 | 2 | 141 | 2 | CID000021320 | |
| Disease | Intellectual Disability | TANC2 HIVEP2 ASH1L PEX6 CHD8 FRY SCN1A ZNF335 PUM1 DYNC1I2 PMM2 | 7.61e-06 | 447 | 136 | 11 | C3714756 |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 7.88e-06 | 9 | 136 | 3 | C3502809 | |
| Disease | smoking cessation | 2.10e-05 | 325 | 136 | 9 | EFO_0004319 | |
| Disease | oxoglutarate dehydrogenase deficiency (implicated_via_orthology) | 2.11e-05 | 2 | 136 | 2 | DOID:0081326 (implicated_via_orthology) | |
| Disease | Tourette syndrome | 8.43e-05 | 50 | 136 | 4 | EFO_0004895 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 1.23e-04 | 55 | 136 | 4 | DOID:9952 (is_implicated_in) | |
| Disease | acute myelomonocytic leukemia (is_implicated_in) | 1.26e-04 | 4 | 136 | 2 | DOID:0081082 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NCOA3 DPYD ERBB3 BRIP1 DVL3 SREBF2 AKAP9 OTOGL YAP1 DIP2C DLEC1 FCRL5 SPEN GAB1 GABRA4 | 1.34e-04 | 1074 | 136 | 15 | C0006142 |
| Disease | Ataxia | 2.04e-04 | 25 | 136 | 3 | C0004134 | |
| Disease | Epidermolysis Bullosa Simplex | 2.09e-04 | 5 | 136 | 2 | C0079298 | |
| Disease | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 3.13e-04 | 6 | 136 | 2 | C3463992 | |
| Disease | bipolar disorder | HIVEP2 ANK3 PODXL PCLO STARD9 PLXNA4 TMEM131 DLEC1 IGSF9B PAX5 | 3.56e-04 | 577 | 136 | 10 | MONDO_0004985 |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 4.36e-04 | 7 | 136 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Profound Mental Retardation | 4.74e-04 | 139 | 136 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.74e-04 | 139 | 136 | 5 | C0025363 | |
| Disease | Mental deficiency | 4.74e-04 | 139 | 136 | 5 | C0917816 | |
| Disease | Neoplasm Metastasis | 5.24e-04 | 217 | 136 | 6 | C0027627 | |
| Disease | X-linked infantile spasms | 5.80e-04 | 8 | 136 | 2 | C4552072 | |
| Disease | Attached earlobe | 5.80e-04 | 8 | 136 | 2 | HP_0009907 | |
| Disease | Prostatic Neoplasms | 5.91e-04 | 616 | 136 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.91e-04 | 616 | 136 | 10 | C0376358 | |
| Disease | Autism Spectrum Disorders | 6.55e-04 | 85 | 136 | 4 | C1510586 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.11e-04 | 152 | 136 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 7.43e-04 | 9 | 136 | 2 | EFO_0600040 | |
| Disease | prostate cancer (is_marker_for) | 7.99e-04 | 156 | 136 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Schizophrenia | DPYD ERBB3 ANK3 SREBF2 ESAM NR3C1 MET EIF2S1 OR4C46 CDC25C NKAPL GABRA4 | 8.18e-04 | 883 | 136 | 12 | C0036341 |
| Disease | Neurodevelopmental Disorders | 9.18e-04 | 93 | 136 | 4 | C1535926 | |
| Disease | Malignant Head and Neck Neoplasm | 1.10e-03 | 44 | 136 | 3 | C0278996 | |
| Disease | hip geometry | 1.10e-03 | 44 | 136 | 3 | EFO_0004685 | |
| Disease | spontaneous preterm birth | 1.25e-03 | 101 | 136 | 4 | EFO_0006917 | |
| Disease | coronary artery disease | SOX6 DPP6 DPYD HIVEP2 HCN1 PPFIA1 RUNX2 IGSF10 FNDC1 KIAA1217 ZNF335 NUP210 DLEC1 PAX5 | 1.26e-03 | 1194 | 136 | 14 | EFO_0001645 |
| Disease | Osteosarcoma | 1.34e-03 | 47 | 136 | 3 | C0029463 | |
| Disease | Colorectal Carcinoma | 1.58e-03 | 702 | 136 | 10 | C0009402 | |
| Disease | renal sinus adipose tissue measurement | 1.59e-03 | 13 | 136 | 2 | EFO_0004864 | |
| Disease | X-19141 measurement | 1.59e-03 | 13 | 136 | 2 | EFO_0800799 | |
| Disease | Epilepsy | 1.65e-03 | 109 | 136 | 4 | C0014544 | |
| Disease | total brain volume change measurement | 1.85e-03 | 14 | 136 | 2 | EFO_0021504 | |
| Disease | cleft lip | 2.09e-03 | 284 | 136 | 6 | EFO_0003959 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.13e-03 | 15 | 136 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.13e-03 | 15 | 136 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.13e-03 | 15 | 136 | 2 | C0154091 | |
| Disease | prostate cancer (is_implicated_in) | 2.14e-03 | 117 | 136 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | response to beta blocker, heart rate | 2.34e-03 | 57 | 136 | 3 | EFO_0004326, EFO_0007766 | |
| Disease | Tremor, Rubral | 2.43e-03 | 16 | 136 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.43e-03 | 16 | 136 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.43e-03 | 16 | 136 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 2.43e-03 | 16 | 136 | 2 | C0240991 | |
| Disease | Abnormal coordination | 2.43e-03 | 16 | 136 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 2.43e-03 | 16 | 136 | 2 | C0427190 | |
| Disease | Pontoneocerebellar hypoplasia | 2.43e-03 | 16 | 136 | 2 | cv:C1261175 | |
| Disease | Stomach Neoplasms | 2.61e-03 | 297 | 136 | 6 | C0038356 | |
| Disease | Squamous cell carcinoma | 2.64e-03 | 124 | 136 | 4 | C0007137 | |
| Disease | Malignant neoplasm of stomach | 2.74e-03 | 300 | 136 | 6 | C0024623 | |
| Disease | Benign neoplasm of stomach | 2.74e-03 | 17 | 136 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.74e-03 | 17 | 136 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.74e-03 | 17 | 136 | 2 | C0154060 | |
| Disease | hyperglycemia (implicated_via_orthology) | 2.74e-03 | 17 | 136 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | disease progression measurement | 2.84e-03 | 61 | 136 | 3 | EFO_0008336 | |
| Disease | Malignant Neoplasms | 2.96e-03 | 128 | 136 | 4 | C0006826 | |
| Disease | Carcinoma of bladder | 3.07e-03 | 18 | 136 | 2 | C0699885 | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.25e-03 | 64 | 136 | 3 | DOID:4947 (is_marker_for) | |
| Disease | carcinoma (implicated_via_orthology) | 3.25e-03 | 64 | 136 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | blood metabolite measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0005664 | |
| Disease | language measurement | 3.49e-03 | 134 | 136 | 4 | EFO_0007797 | |
| Disease | ovarian neoplasm | 3.49e-03 | 134 | 136 | 4 | C0919267 | |
| Disease | eosinophil count | CCDC117 ERBB3 HIVEP2 FERMT1 TNFRSF10C NR3C1 RUNX2 GGT5 FNDC1 LIMK2 SEPSECS AKAP9 TMEM131 CDC25C LRRC36 | 3.65e-03 | 1488 | 136 | 15 | EFO_0004842 |
| Disease | Malignant neoplasm of ovary | 3.78e-03 | 137 | 136 | 4 | C1140680 | |
| Disease | Abnormality of refraction | 4.08e-03 | 673 | 136 | 9 | HP_0000539 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 4.18e-03 | 21 | 136 | 2 | C1292769 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.18e-03 | 21 | 136 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Stomach Carcinoma | 4.18e-03 | 21 | 136 | 2 | C0699791 | |
| Disease | Manic Disorder | 4.35e-03 | 71 | 136 | 3 | C0024713 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.59e-03 | 22 | 136 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | X-24947 measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0800910 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TDSPVTMKSSSEPGY | 111 | P59817 | |
| PSMTTIHGLPYSAST | 726 | Q8N944 | |
| PGETAPSMRLLAYVS | 106 | Q8WW43 | |
| PRGSQSLLSPSSGYM | 1041 | P21860 | |
| TYSRQGMSPTFSRSP | 381 | O94929 | |
| TDESIPSYSGSDMPR | 1791 | Q99996 | |
| PRPTGMSLYNSLETA | 256 | Q8IWD4 | |
| SRTPLLSMSTYPSVP | 1456 | Q9NR48 | |
| GTTPSEMYLPVRFSS | 836 | Q8TDY4 | |
| YEMRVSPSDTTPLVS | 2041 | Q9HCK8 | |
| VITLMGTPSGTAEPY | 101 | Q9NW68 | |
| GSMTYSASLPLPLSS | 571 | Q9H201 | |
| SSVSPGLYSKTMTPI | 176 | Q9BQL6 | |
| YVGLTMAASTSFPPR | 2926 | Q8WXG9 | |
| MTRTDPPDLLVSTVY | 1 | C9J069 | |
| VSPRIIRGTTSGPMY | 586 | Q12882 | |
| EGSPRTYSRLSVPMP | 471 | Q8TDJ6 | |
| MGPPSSSGFYVSRAV | 1 | Q6Q4G3 | |
| TFPAYGMSPSLSTIT | 371 | Q92997 | |
| VTETPEPAMTSGVYR | 156 | Q9UKY7 | |
| MVRPGYSHRVSLPTS | 136 | Q9H714 | |
| RMITQTSITPYIASP | 281 | P29558 | |
| KMLPTYVRSTPEGSE | 56 | P35557 | |
| SYSAPTLTGMVPGSE | 326 | Q02548 | |
| VSPVSYLRVSMSPVL | 1371 | Q8TEM1 | |
| GTPSRNYPATSMVSG | 111 | Q8WXI7 | |
| NYPATSMVSGLSSPR | 116 | Q8WXI7 | |
| TSTMPYLTETPLAVT | 4406 | Q8WXI7 | |
| STVLYKMPSGATPEV | 9601 | Q8WXI7 | |
| YPVGTPSSMAETSIS | 10131 | Q8WXI7 | |
| ESPTVSTMIHYLGPE | 401 | Q5VV17 | |
| IPGYTFTSPGMTTTL | 221 | O00592 | |
| LSPSSSYSPEMGRVV | 261 | Q8NGI7 | |
| SDMPRDSGIYDSSVP | 656 | Q8NFM7 | |
| PPTTVAGATLYSVAM | 266 | Q9H3K2 | |
| LPYSVTLISMPATTE | 146 | P53671 | |
| SGMTSRLTPSVTPAY | 541 | Q03001 | |
| SSYCIPTAGMSPSRS | 371 | Q13480 | |
| APPRYVMTTTTLERT | 231 | P05198 | |
| IIPSMSVSIYPSSAE | 881 | O15550 | |
| SVPYGMATVIRSPLR | 146 | Q9HDC5 | |
| TPCRTAYATTAPMTP | 741 | Q5VZ46 | |
| SMGLTPESPIVFSEY | 66 | Q13409 | |
| ATTSMTTVGYGDIRP | 386 | Q6PIU1 | |
| STEPSDYLRVASGPM | 136 | P0C7W9 | |
| AGISTPQYSTARMTP | 3056 | Q9Y6V0 | |
| SQPMPRSYFITTGAS | 3136 | Q9Y6V0 | |
| RYTGSPDSLRSRTPM | 1626 | Q9HCM2 | |
| KAATMPYSVISDSPR | 261 | Q96RD9 | |
| YSPRQSTVRSPEKMT | 256 | Q1X8D7 | |
| TTDPRMARSSPYPTD | 436 | Q9ULD0 | |
| MARSSPYPTDVARVV | 441 | Q9ULD0 | |
| TITASPSLGSPMYLS | 46 | A6NHA9 | |
| YQTPPSSPSTTMSRK | 256 | O43312 | |
| YTVTSMTTTTPLGPT | 1771 | Q02505 | |
| SVLMGESQPYSGPRT | 291 | P35913 | |
| HTSLYMVGSTLSPVP | 406 | Q13608 | |
| SAAGSTYEPSPMRLE | 676 | Q6AI08 | |
| RSMSSIPPYPASSLA | 676 | Q13136 | |
| SPLTRSLYVNMTSGP | 26 | Q9H1A3 | |
| TSNMSIYDILRPGTP | 266 | Q8NEV8 | |
| RMPTYSQFSPSSLVG | 116 | Q8ND56 | |
| PTSIRTGYMPRKASV | 456 | P48169 | |
| RTVFSNGYSSPSMRP | 386 | P04150 | |
| PYSEVVTSAPGTMTR | 1586 | Q6ZVL6 | |
| TATMPPAVERLARSY | 606 | Q9BUQ8 | |
| AYPSTSRGLKTMPEA | 281 | Q9GZU2 | |
| MYPESTTGSPARLSL | 1 | Q13303 | |
| VSRSGLYRSPSMPEN | 206 | P30307 | |
| GLGVSMVEYVLSSSP | 216 | Q14671 | |
| TAYSGVPMTILSSRD | 266 | Q9BX63 | |
| IGFTTDPRMARSSPY | 446 | Q02218 | |
| VSMSPRVYVPLITAS | 146 | Q8NG75 | |
| SVGKSSSYPMVSESP | 46 | P36888 | |
| LSLDRSGSPMVPSYE | 311 | Q9Y2I7 | |
| MSGPVPSRARVYTDV | 1 | Q8NEV1 | |
| PTSRMRTQSPPVYTA | 656 | O60741 | |
| VTPTGAVMTYAPTSI | 1136 | Q6WRI0 | |
| SRIMYDLTSKPPGTT | 676 | P49915 | |
| SSSDPYTASSRGMLP | 1051 | Q4ZHG4 | |
| VGFPPVMERYTSAVS | 136 | Q96MF6 | |
| SGPDPTTVYVDMRAL | 1311 | Q9Y2E4 | |
| TINTPFGAMVYSPRT | 406 | P36269 | |
| YLTEPGMIERSTGAT | 1471 | Q12955 | |
| QTMRLGRSPSYLSSP | 331 | Q494V2 | |
| MSGPVPSRARVYTDV | 1 | P68400 | |
| VTTSKPGVSLVYSMP | 91 | Q96AP7 | |
| LSSSMIPGYTGFVPR | 86 | A8MTA8 | |
| VSLAPMPTPRYAATS | 156 | Q8IYD2 | |
| MPTPRYAATSFLRGS | 161 | Q8IYD2 | |
| SPLLRYSFETMAPTG | 41 | Q9BZJ6 | |
| MSCPGSSYRTVVRPT | 66 | Q96A84 | |
| PEIMATTPDGTVSYD | 941 | Q5TBA9 | |
| PYHATVPEMSILGTS | 171 | P55286 | |
| SRVPIMELPTYTGSI | 321 | P42658 | |
| NMGTLPRSLYSTSPR | 421 | Q9Y3R0 | |
| PAGGSSTIYISFTPM | 1396 | Q9Y238 | |
| STEPSDYLRVASGPM | 136 | A8MXJ8 | |
| TDSEPRQEVPMYTGS | 441 | Q96EK7 | |
| RTSPEYGMPSVTFGS | 166 | Q9UNL4 | |
| DGYVLPSSTTREMTP | 1101 | P46019 | |
| DSGSMYVITTPAGLI | 1641 | Q3ZCN5 | |
| QPSLGTTSSHTMLPY | 1911 | Q5THK1 | |
| STYTEGSTPLTSMPV | 681 | Q685J3 | |
| PTSTYSEGRTPLTSM | 856 | Q685J3 | |
| SMPTSTYSEGRTPLT | 1326 | Q685J3 | |
| YSDRRTPLTSMPVST | 2156 | Q685J3 | |
| TSTYSEGSTPLRSMP | 2566 | Q685J3 | |
| PTSTYSEGSTPLTNM | 3331 | Q685J3 | |
| PLTYVTMSTAPSTPR | 4001 | Q685J3 | |
| FTDPRTMGYSVTAPE | 221 | O15305 | |
| YPLTDMSPILTSGDS | 1026 | P08581 | |
| DYLASPTTEMTSPGL | 456 | Q96NL0 | |
| ATFTYTPPVTSGMSL | 396 | Q13950 | |
| VARYPPIVASMTADS | 41 | Q9NP92 | |
| LSPLLSTSEYGVMSP | 126 | Q8NET4 | |
| IATPLRSPAYGAMSA | 806 | Q8NET4 | |
| LTYEELPGTPAMATT | 36 | Q9BQS2 | |
| SSARSMFSPYREGPI | 181 | A6NEV1 | |
| SSPPYLTSTRSLSPM | 1516 | A2VDJ0 | |
| GYLSSAVLPSPRKSM | 276 | Q6IFN5 | |
| STEPSDYLRVASGPM | 136 | P0C7W8 | |
| PSPSSERAVYMTAPS | 456 | A1L4K1 | |
| STESSVYLRVASGPM | 136 | D6RGX4 | |
| MPSSRAYGLADPSTT | 411 | Q9Y6Q9 | |
| TTYDGIDALPIPSSM | 401 | Q8WXH5 | |
| SPSRIPYGGTRSMVV | 326 | Q5T5P2 | |
| PPAESMSVYRSQSGS | 1546 | Q9HCD6 | |
| YTMLGTPASVGLTPR | 111 | Q9P2P6 | |
| STEPSDYLRVASGPM | 136 | P0C7V4 | |
| ADVSRPPGSTVYTCM | 596 | Q9UL12 | |
| TMSTAACPPSYDRVT | 1976 | P35498 | |
| VVYPGAITMATTTPS | 741 | P35712 | |
| FIVSTGPYPSESAMT | 56 | Q08188 | |
| SSPASAPIGRYTMAL | 101 | Q08188 | |
| PLPSDIAVIMYTSGS | 276 | O95573 | |
| MPPVSRSSYSEDIVG | 1 | Q5M9Q1 | |
| PGTSTRYVMPSCESD | 281 | Q9H4F8 | |
| MGLRPVSYTDSSVTP | 96 | Q13009 | |
| GEVRMNTPTLPSITY | 3096 | Q96T58 | |
| PPLLEVTTFYSEGMS | 416 | Q7Z2H8 | |
| YSEVLGRPTTLSETM | 236 | P06133 | |
| SPSYRPAMGFTTLAT | 1266 | Q9UPX0 | |
| ERVMTRSYGATATSP | 131 | Q8TB61 | |
| GISPMSTRDPYATIT | 236 | Q9NXZ1 | |
| YSVSAGDPPVTVMSL | 791 | Q9NXZ1 | |
| SFVDSVGVMSPPLSR | 846 | Q12772 | |
| PPYETKGVMRASFSS | 271 | Q92545 | |
| SVRPVLDIYSASGMP | 61 | Q9H269 | |
| ETMITSPGTPASSHY | 226 | O14798 | |
| GLSMSSYSVPRTPDD | 401 | P46937 | |
| YQRGSSMVLFSSPPV | 226 | P04156 | |
| PASYGSTTTKPMGLL | 506 | Q8WVM8 | |
| TPLFSTATPGYTMAS | 261 | Q9P273 | |
| LPYTASSGLMAPREV | 181 | Q15904 | |
| GYSSDVLSARPTMSP | 86 | Q6ZWC4 | |
| SMSSLSSEGDYAIPP | 531 | Q9ULM0 | |
| MTSVASLPEQSPGYR | 1 | Q8N9P0 | |
| ISKMYPGRASASPSL | 306 | Q9HD40 | |
| YSEVLGRPTTLSETM | 236 | P16662 | |
| IVSTPVGIMASDYDP | 716 | P31629 | |
| YSVITAPPMEEGTSA | 881 | Q9H4Z2 | |
| GYRLFSSSRPPTEMK | 1001 | Q6PFW1 | |
| CRMETEYGPSVTSIP | 2711 | Q9NR99 | |
| SRPGTYGMLSSLTEE | 36 | Q9HD90 |